Flagship Harbor Advisors LLC increased its position in shares of Cooper Companies Inc (NYSE:COO) by 62.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 78 shares of the medical device company’s stock after acquiring an additional 30 shares during the period. Flagship Harbor Advisors LLC’s holdings in Cooper Companies were worth $26,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of COO. Veritas Asset Management LLP lifted its stake in Cooper Companies by 77.8% during the 1st quarter. Veritas Asset Management LLP now owns 981,302 shares of the medical device company’s stock worth $290,632,000 after acquiring an additional 429,340 shares in the last quarter. Swedbank acquired a new stake in Cooper Companies in the 2nd quarter valued at about $100,362,000. Robeco Institutional Asset Management B.V. raised its position in Cooper Companies by 478.9% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 155,078 shares of the medical device company’s stock valued at $52,245,000 after purchasing an additional 128,289 shares in the last quarter. Janus Henderson Group PLC raised its position in Cooper Companies by 4.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,834,318 shares of the medical device company’s stock valued at $839,449,000 after purchasing an additional 112,906 shares in the last quarter. Finally, California Public Employees Retirement System raised its position in Cooper Companies by 31.8% in the 1st quarter. California Public Employees Retirement System now owns 305,419 shares of the medical device company’s stock valued at $90,456,000 after purchasing an additional 73,732 shares in the last quarter. 96.86% of the stock is currently owned by hedge funds and other institutional investors.
In other news, VP Randal Golden sold 1,154 shares of the stock in a transaction dated Wednesday, June 19th. The stock was sold at an average price of $328.16, for a total value of $378,696.64. Following the transaction, the vice president now owns 1,148 shares in the company, valued at approximately $376,727.68. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jody S. Lindell sold 3,000 shares of the stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $328.29, for a total value of $984,870.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 77,678 shares of company stock worth $25,063,536. Company insiders own 1.70% of the company’s stock.
COO opened at $325.68 on Tuesday. Cooper Companies Inc has a one year low of $228.65 and a one year high of $343.33. The stock has a market cap of $16.57 billion, a P/E ratio of 28.32, a P/E/G ratio of 2.54 and a beta of 0.90. The company has a current ratio of 1.21, a quick ratio of 0.68 and a debt-to-equity ratio of 0.42. The firm has a 50-day simple moving average of $332.84.
Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, May 30th. The medical device company reported $2.94 EPS for the quarter, beating analysts’ consensus estimates of $2.76 by $0.18. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. The business had revenue of $654.30 million for the quarter, compared to the consensus estimate of $655.00 million. During the same quarter in the prior year, the business posted $2.86 EPS. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. Analysts forecast that Cooper Companies Inc will post 12.27 EPS for the current year.
The firm also recently disclosed a Semi-Annual dividend, which will be paid on Wednesday, August 7th. Stockholders of record on Tuesday, July 23rd will be issued a $0.03 dividend. The ex-dividend date is Monday, July 22nd. Cooper Companies’s payout ratio is currently 0.52%.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Article: How can you know how many shares are floating?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.